USD
( +0.00%
At Close (As of Jan 1, 1970)
$5.51M
Market Cap
-
P/E Ratio
-105.51
EPS
$37.44
52 Week High
$0.50
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $2.9M |
| Total Revenue | $6.5M |
| Cost Of Revenue | $3.7M |
| Costof Goods And Services Sold | $3.7M |
| Operating Income | -$8.1M |
| Selling General And Administrative | $9.1M |
| Research And Development | $490K |
| Operating Expenses | $11M |
| Investment Income Net | - |
| Net Interest Income | -$1.1M |
| Interest Income | - |
| Interest Expense | $1.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $920K |
| Income Before Tax | -$9.1M |
| Income Tax Expense | -$23K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$9.1M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$8.1M |
| Ebitda | -$7.1M |
| Net Income | -$9.1M |
| Field | Value (USD) |
|---|---|
| Total Assets | $46M |
| Total Current Assets | $1.3M |
| Cash And Cash Equivalents At Carrying Value | $741K |
| Cash And Short Term Investments | $741K |
| Inventory | $220K |
| Current Net Receivables | $175K |
| Total Non Current Assets | $45M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $18M |
| Intangible Assets Excluding Goodwill | $18M |
| Goodwill | $24M |
| Investments | - |
| Long Term Investments | $741K |
| Short Term Investments | - |
| Other Current Assets | $182K |
| Other Non Current Assets | - |
| Total Liabilities | $34M |
| Total Current Liabilities | $18M |
| Current Accounts Payable | $5.7M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $6.6M |
| Total Non Current Liabilities | $16M |
| Capital Lease Obligations | $2.4M |
| Long Term Debt | $1.1M |
| Current Long Term Debt | $6.3M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $9.9M |
| Other Current Liabilities | $5M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $13M |
| Treasury Stock | - |
| Retained Earnings | -$67M |
| Common Stock | $37 |
| Common Stock Shares Outstanding | $310K |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$3M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $920K |
| Capital Expenditures | $184K |
| Change In Receivables | - |
| Change In Inventory | $45K |
| Profit Loss | - |
| Cashflow From Investment | $364K |
| Cashflow From Financing | $3.1M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$9.1M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $2.9M |
| Total Revenue | $6.5M |
| Cost Of Revenue | $3.7M |
| Costof Goods And Services Sold | $3.7M |
| Operating Income | -$8.1M |
| Selling General And Administrative | $9.1M |
| Research And Development | $490K |
| Operating Expenses | $11M |
| Investment Income Net | - |
| Net Interest Income | -$1.1M |
| Interest Income | - |
| Interest Expense | $1.1M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $920K |
| Income Before Tax | -$9.1M |
| Income Tax Expense | -$23K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$9.1M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$8.1M |
| Ebitda | -$7.1M |
| Net Income | -$9.1M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
INVO Fertility, Inc. is a pioneering healthcare provider in the fertility industry, headquartered in Sarasota, Florida. The company specializes in cutting-edge assisted reproductive technology, notably through its proprietary INVOcell® platform, which delivers a more accessible and cost-effective solution for in vitro fertilization. With a commitment to improving patient outcomes and addressing the increasing demand for reproductive services, INVO Fertility emphasizes a patient-centric approach while actively forming collaborations within the broader healthcare community. This innovative focus positions the company as a leader in the evolving landscape of fertility care.